EnteroBiotix
EnteroBiotix is a clinical-stage biotechnology company that develops full-spectrum microbiome therapeutics to treat gastrointestinal diseases, liver cirrhosis, and blood cancer. The company utilizes its proprietary AMPLA drying technology to create orally delivered, refrigerator-stable medicinal powders from screened donor material. Its lead candidate, EBX-102-02, is currently undergoing clinical trials specifically targeting patients with Irritable Bowel Syndrome (IBS).
Biotechnology
Microbiome Therapeutics
Pharmaceuticals
Healthcare
Funding summary
- Total raised
- €42.5M
- Funding rounds
- 3
Investors in EnteroBiotix
Investors on record for EnteroBiotix. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like EnteroBiotix?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors